ABIGAIL GRAVES: Open Payments
NPI 1003551128 · CAMBRIDGE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,157 in 47 payments from 12 companies in 2025. Trend: 2023 $419 · 2024 $1,234 · 2025 $1,157
Food & beverage: $1,057Education: $100
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 23 | $383 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $166 |
| HARMONY BIOSCIENCES LLC | 3 | $163 |
| Grifols USA, LLC | 4 | $107 |
| Verona Pharma, Inc. | 3 | $78 |
| Lilly USA, LLC | 1 | $72 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| Amgen Inc. | 2 | $40 |
| GENZYME CORPORATION | 2 | $37 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
Products named: NUCALA, OFEV, Prolastin-C Liquid, TRELEGY ELLIPTA, Ohtuvayre, ZEPBOUND, WAKIX, JASCAYD.
Industry payments across NY — which companies pay providers there.
